Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro

Medical Science Monitor

Volumn 18, Issue 8, 2012, Pages

  Lü, Jian Ming ^a   Yan, Shaoyu ^a   Jamaluddin, Saha ^a   Weakley, Sarah M ^a   Liang, Zhengdong ^a   Siwak, Edward B ^a   Yao, Qizhi ^a   Chen, Changyi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cytotoxicity; Ginkgolic acid; HIV infection; HIV protease inhibitor

Indexed keywords

ANTIVIRUS AGENT; GINKGOLIC ACID; PLANT EXTRACT; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEINASE INHIBITION;

EID: 84866080363     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.883261     Document Type: Article

References (23)

1. UNAIDS/WHO. AIDS Epidemic Update. December 2010: http://www. unaids.org
2. Erickson JW: HIV-1 protease as a target for AIDS therapy, in Protease inhibitors in AIDS therapy. Ogden RC, Flexner CW (eds.). Marcel Dekker, Inc.: New York, N.Y. 2001; 1-25
3. Reisler RB, Han C, Burman WJ et al: Grade 4 events are as important as AIDS events in the era of HAART. J Acquir Immune Defic Syndr, 2003; 34: 379-86
4. De Clercq E: Highlights in the development of new antiviral agents. Mini Rev Med Chem, 2002; 2: 163-75
5. OARAC. DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents. 2008 November 3, 2008 [cited 2010 Aug. 18]; Available from: http://aidsinfo.nih.gov
6. De Clercq E: Antiviral drugs in current clinical use. J Clin Virol, 2004; 30: 115-33
7. Moore JP, Doms RW: The entry of entry inhibitors: a fusion of science and medicine. Proc Natl Acad Sci USA, 2003; 100: 10598-602
8. Dorsey BD, McDonough C, McDaniel SL et al: Identification of MK-944a: a second clinical candidate from the hydroxylaminepentanamide isostere series of HIV protease inhibitors. J Med Chem, 2000; 43: 3386-99
9. Navia MA, Fitzgerald PM, McKeever BM et al: Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. Nature, 1989; 337: 615-20
10. Chang RS, Yeung HW: Inhibition of growth of human immunodeficiency virus in vitro by crude extracts of Chinese medicinal herbs. Antiviral Res, 1988; 9: 163-75
11. Lu W: Prospect for study on treatment of AIDS with traditional Chinese medicine. J Tradit Chin Med, 1995; 15: 3-9
12. Collins RA, Ng TB, Fong WP et al: A comparison of human immunodeficiency virus type 1 inhibition by partially purified aqueous extracts of Chinese medicinal herbs. Life Sci, 1997; 60: PL345-51
13. Lam TL, Lam ML, Au TK et al: A comparison of human immunodeficiency virus type-1 protease inhibition activities by the aqueous and methanol extracts of Chinese medicinal herbs. Life Sci, 2000; 67: 2889-96
14. Zhou W, Chai H, Lin PH et al: Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular diseases. Cardiovasc Drug Rev, 2004; 22: 309-19
15. Liu ZH, Zeng S: Cytotoxicity of ginkgolic acid in HepG2 cells and primary rat hepatocytes. Toxicol Lett, 2009; 187: 131-36
16. Jaggy H, Koch E: Chemistry and biology of alkylphenols from Ginkgo biloba L. Pharmazie, 1997; 52: 735-38
17. Fuzzati N, Pace R, Villa F: A simple HPLC-UV method for the assay of ginkgolic acids in Ginkgo biloba extracts. Fitoterapia, 2003; 74: 247-56
18. Choi YH, Choi HK, Peltenburg-Looman AM et al: Quantitative analysis of ginkgolic acids from Ginkgo leaves and products using 1H-NMR. Phytochem Anal, 2004; 15: 325-30
19. The EnzoLyte™ 520 HIV-1 protease assay kit, [cited 2010 Aug. 18]; Available from: http://www.anaspec.com/products/product.asp?id=30170
20. Deeks SG, Smith M, Holodniy M, Kahn JO: HIV-1 protease inhibitors. A review for clinicians. JAMA, 1997; 277: 145-53
21. http://www.rxlist.com/cgi/generic/ritonavirsol_ad.htm [cited 2010 Aug. 18]
22. Lee JS, Hattori M, Kim J: Inhibition of HIV-1 protease and RNase H of HIV-1 reverse transcriptase activities by long chain phenols from the sarcotestas of Ginkgo biloba. Planta Med, 2008; 74: 532-34
23. Chao JC, Chu CC: Effects of Ginkgo biloba extract on cell proliferation and cytotoxicity in human hepatocellular carcinoma cells. World J Gastroenterol, 2004; 10: 37-41